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A B S T R A C T
Background. Young adult patients (pts) with repaired tetralogy of Fallot (TOF) remain at risk for arrhythmias (Ar)
and sudden cardiac death (SCD). Based on past studies with earlier pt subsets, Ar/SCD events were associated with
right ventricular (RV) systolic pressures >60 mm Hg, outﬂow tract gradients >20 mm Hg, and QRS duration
>180 ms. However, there are limited recent studies to evaluate these risk factors in the current patient generation.
Methods. Patients with TOF followed over the past 50 years were grouped by presence of any arrhythmias (group
1), absence of arrhythmias (group 2), and presence of SCD or signiﬁcant ventricular arrhythmias (group 3) and
correlated with current pt age, gender, age at repair, repair types, echocardiogram, cardiac magnetic resonance
imaging, electrocardiogram/Holter, hemodynamics, and electrophysiology ﬁndings.
Results. Of 109 pts, 52 were male aged 17–58 years. Of these, 59 (54%) had Ar, two of whom had SCD. These 59
pts were chronologically older at the time of analysis, with repair at an older age and wider QRS duration (78–240,
mean 158 ms) when compared with those without Ar. However, there was no correlation with surgical era, surgical
repair, gender, RV pressure >60 mm Hg, right ventricular outﬂow tract gradient >20 mm Hg, or RV end-diastolic
volume on CMRI.
Conclusions. Ar/SCD risk continues to correlate with repair age and advancing pt age. QRS duration is longer in
these patients but at a shorter interval (mean 158 ms) and less RV pressure (mean 43 mm Hg) than previously
reported. In the current TOF patient generation, neither surgical era, type of repair, RV outﬂow gradient nor RV
volume correlate with Ar/SCD. Electrophysiologic testing to verify and identify arrhythmias remains clinically
effective.
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Introduction
Surgical repair of tetralogy of Fallot (TOF), themost common cyanotic congenital heart
disease, has seen tremendous advances since ﬁrst
performed 50 years ago and is now performed
earlier than in previous decades. Successful
surgery has led to an increasing population of
adults with repaired TOF. However, with this
increased life expectancy, this group of patients
(pts) also suffers from late complications, notably
arrhythmias resulting in morbidity and mortality
often years after repair.1,2 Studies in the 1980s
reported an increased risk of arrhythmias and
sudden cardiac death (SCD) associated with
certain clinical risk factors: late deﬁnitive repair
following an initial palliation, presence of a tran-
sannular patch, signiﬁcant pulmonary and/or tri-
cuspid insufﬁciency, severe right ventricular (RV)
and right atrial enlargement, elevated right ven-
tricular systolic pressure (RVSP), increased right
ventricular outﬂow tract (RVOT) pressure gradi-
ent, and a prolonged QRS duration.3–8 Electro-
physiological studies (EPSs) have been shown to
have prognostic value in identifying pts at risk
for signiﬁcant arrhythmias.9 More recently, focus
has shifted toward discerning the role of left ven-
tricular dysfunction in arrhythmia generation.10
However, despite the availability of several tech-
niques, no single variable has been identiﬁed to be
predictive of arrhythmias potentially predisposing
to SCD among patients with repaired TOF. The
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purpose of this study was to reevaluate the previ-
ously reported risk factors and to determine if
those still hold true in the current era.
Materials and Methods
A retrospective chart review was conducted on
all pts above 17 years of age with at least 10 years
of postsurgical follow-up with repaired TOF/
pulmonary atresia (PA) followed at the Michigan
Adult Congenital Heart Clinic of the Children’s
Hospital of Michigan, Detroit Medical Center.
The study was approved by the Wayne State Uni-
versity Institutional Review Board. Patients who
did not have complete repair and had only a pallia-
tive shunt as well as those followed elsewhere post-
operatively, and in whom clinical data was not
available, were excluded. A total of 109 pts meeting
the 10-year postrepair inclusion criteria were iden-
tiﬁed, all of whom had undergone surgical repair
between 1970 and 1995 and were followed at
the Children’s Hospital of Michigan Section of
Cardiology with available clinical data. This
accounted for approximately three fourth of all
patients who had undergone complete surgical
TOF repair during that time interval and subse-
quently followed at our institution. Reviewed clini-
cal data included patient complaints/symptoms
including fatigue, palpitations, sustained arrhyth-
mias, syncope/presyncope, and any evidence of
aborted sudden death. Noninvasive testing (elec-
trocardiogram [ECG], ambulatory monitoring/
Holter and exercise stress testing) and Doppler/
echocardiographic data (chamber dimensions,
contractility indices, RVSPs, RVOT pressure gra-
dients, valve integrity, and left ventricular function)
were reviewed. Data obtained during cardiac cath-
eterization included all hemodynamic measure-
ments, and results of EPSs were recorded. Patients
were grouped by presence of atrial and/or ventricu-
lar arrhythmias (group 1), absence of arrhythmias
(group 2), and presence of SCD or signiﬁcant ven-
tricular arrhythmias (group 3), which was a sub-
group of group 1.
Statistical Analysis
Data were analyzed using SPSS software (version
20; SPSS Inc, Chicago, IL, USA). Fisher’s exact
test was used to compare categorical data, and
two-tailed Student’s t-test was used to compare
means. Results are presented as mean value ± stan-
dard deviation. Signiﬁcance was deﬁned as a P
value < .05. The 95% conﬁdence interval was cal-
culated wherever appropriate.
Results
Demographics
A total of 109 pts were identiﬁed, all of whom
underwent surgical repair between 1970 and 1995.
The mean age of the cohort was 29 ± 11 years
(median age: 27 years, range 17–58) of whom 52
(48%) were male. Mean age at intracardiac repair
was 41.2 ± 48 months (median: 24, range 1–216
months). Mean years of follow-up postintracardiac
repair was 23.4 ± 8 years (median: 22, range 10–50
years). Uncomplicated TOF was seen in 93 pts
(85%), whereas 16 pts (15%) had pulmonary
atresia with VSD (PA-VSD). An initial aorto-
pulmonary shunt prior to intracardiac repair was
performed in 54 pts (50%): 50 of those were
Blalock–Taussig–Thomas (BTT) shunts (classic
and modiﬁed) and four were central aorto-
pulmonary shunts (Waterston or Potts). Outﬂow
tract repair consisted of a transannular patch in 67
pts (61%), whereas 11 pts (10%) were repaired
without a transannular patch. A right ventricle to
pulmonary artery conduit was performed in 27
(25%) pts: 11 (10%) of these patients with TOF
and 16 (15%) with PA-VSD (Table 1).
Patients and Complaints
Of the 109 patients, 73 (67%) were clinically
symptomatic with complaints of fatigue, palpita-
tions, syncope, or presyncope. Of these com-
plaints, fatigue only was the most common,
occurring in 50 (46%). At the time of their latest
evaluation, 59 patients were in functional New
York Heart Association (NYHA) class I, 44 were in
NYHA class II, three were in NYHA class III, and
three were in NYHA class IV. The median age of
patients in NYHA class I (26, range 17–58 years)
did not differ signiﬁcantly with patients in NYHA
class II (29, range 17–51 years). The small number
of patients with NYHA III and IV precluded any
effective comparisons of median ages with other
groups. Other complaints including palpitations
were seen among 32 (29%) patients. Bonaﬁde
arrhythmias that included supraventricular tachy-
cardia in the form of atrial ﬂutter or intra-atrial
reentrant tachycardia, ventricular ectopy deﬁned
by Lown’s criteria class C (multifocal premature
ventricular complexes [PVCs], couplets/triplets),
nonsustained or sustained ventricular tachycardias
or ventricular ﬁbrillation, and/or aborted SCD
were documented in 59 (54%) patients (group 1).
In spite of their subjective complaints, including
sensed tachycardias, 50 patients (group 2) exhib-
ited no arrhythmias by clinical testing.
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There was a signiﬁcant difference between
groups in mean age at latest evaluation: group 1,
32.9 ± 11 years (median: 31, range 17–58 years) vs.
group 2, 25 ± 8 (median: 22, range 17–53 years)
(P = .0001). Similarly, there was a signiﬁcant dif-
ference between groups in regard to age at intra-
cardiac repair (50 ± 53 vs. 30 ± 38 months [P =
.03]). Median age at repair was also determined.
Median age at repair of group 1 was 36 months
(range 1–216 months) and that for group 2 was
17.5 months (range 3–204 months). Mean years of
follow-up postintracardiac repair was also signiﬁ-
cantly different between the two groups (group 1:
26 ± 9 vs. group 2: 21 ± 7 years, P = .003). In group
1, 30/51 (59%) pts had an initial aortopulmonary
shunt, either BTT (28) or Waterston (2) prior to
intracardiac repair, whereas in group 2, 24/47
(51%) pts underwent a shunt procedure, BTT (22)
and Waterston (2) (P = NS). Intracardiac repair
consisted of a transannular patch in 34 pts from
group 1 and 33 pts in group 2 (P = NS). Similarly,
no signiﬁcant differences were found for patients
without a transannular patch or right ventricle to
pulmonary artery conduit repair between the two
groups.
SCD/Aborted SCD
There was one sudden death and one aborted
sudden death in our cohort among group 1
patients. The one patient who suffered SCDwas 17
years old. He had typical TOFwith a shunt surgery
at 2 months of age and intracardiac repair with a
transannular patch performed at 18 months of age.
He presented in refractory ventricular ﬁbrillation.
The patient with aborted SCD was a 53-year-old
male with typical TOF, who underwent an initial
shunt procedure and subsequent intracardiac repair
with a transannular patch. He had undergone
an apparently successful ablation for ventricular
tachycardia with a negative repeat EPS 4 years
previously. This patient presented with ventricular
tachycardia requiring cardioversion and received
an implantable cardiac deﬁbrillator (ICD).
Ultrasound and Catheterization Data
Based on echocardiographic end-diastolic RV
dimensions, 52 patients had evidence of moder-
ate to severe RV dilation, 26 (47%) of whom
were in group 1 and 26 (55%) in group 2. This
difference was not signiﬁcant (P = .4). Accord-
ingly, moderate to severe right atrial dilation was
Table 1. Comparative Demographic, Clinical, Echocardiographic, Electrocardiographic, and MRI Data among Patients
with/without Arrhythmia
Group 1 (Arrhythmias) Group 2 (No Arrhythmias) P value
Demographic data
Number of patients 59 50
Mean age (years) 32.9 (11.1) 25 (8.3) .0001
Mean follow-up (years) 25.7 (8.9) 20.6 (7.1) .003
Surgical characteristics
Mean age at repair (months) 50.4 (53.3) 29.5 (38.2) .03
Prior aortopulmonary shunt 30 (59%) 24 (51%) 1.0
Type of repair
Transannular patch 34 (61%) 33 (67%) .5
No transannular patch 06 (11%) 05 (10%) 1.0
RV to PA conduit 16 (29%) 11 (22%) 1.0
Echocardiography
Patients with RVSP ≥60 7 (17%) 5 (14%) .7
Mean RVSP (mm Hg) 42.5 (16.5) 37.1 (13.2) .1
Patients with RVOT gradient ≥20 12 (32%) 9 (24%) .4
Mean RVOT gradient (mm Hg) 16.8 (12.1) 17.6 (16.8) .8
Patients with moderate to severe PI 34 (68%) 35 (74%) .5
Patients with moderate to severe RV dilatation 26 (47%) 26 (55%) .4
Patients with moderate to severe RA dilatation 11 (20%) 11 (23%) .8
Mean LVEF (%) 61.9 (7.9) 64.3 (7.7) .2
Mean FS (%) 34.8 (5.0) 34.9 (5.8) .9
Electrocardiogram
Patients with QRS duration ≥180 ms 14 (27%) 3 (7%) .01
Mean QRS duration (ms) 158 (28) 149 (19) .07
MRI
RVEDVi (mL/m2) 162 154 .6
RVEF (%) 38.1 45 .07
PRF (%) 53 44 .08
FS, fractional shortening; LVEF, left ventricular ejection fraction; PI, pulmonary insufficiency; RA, right atrium; RVOT, right ventricular outflow tract; RVSP, right
ventricular systolic pressure.
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seen in 22 of the 109 patients with, again, no
signiﬁcant differences between groups (11 vs. 11,
P = .8). Moderate to severe tricuspid insufﬁciency
was seen in nine patients (group 1 = 4; group 2 =
5, P = .7). Moderate to severe pulmonary insuf-
ﬁciency was seen in 34 (68%) of patients in
group 1 and 35 (74%) of patients in group 2 (P =
NS). Similarly, there was no difference in the
number of patients with an estimated elevated
RVSP >60 mm Hg (group 1: seven [17%] and
group 2: ﬁve [14%] patients). The mean RVSP
did not signiﬁcantly differ between the two
groups (43.0 ± 16 mm Hg vs. 37.2 ± 13 mm Hg,
P = .1). Similarly, for RVOT pressure gradients,
there was no difference in the number of patients
with RVOT gradient >20 mm Hg in the two
groups (group 1: 12, 32% patients and group 2:
9, 24% patients). The mean RVOT gradient in
group 1 was 16.8 ± 12 mm Hg vs. group 2: 17.6
± 17 mm Hg. This difference was also statistically
nonsigniﬁcant.
Noninvasive Arrhythmia Evaluations
Nearly all patients exhibited a typical postsurgical
right bundle branch block ECG pattern. QRS
durations were measured directly from their
latest electrocardiogram. Among patients in
group 1, 14/51 (27%) had a QRS duration
≥180 ms, whereas only 3/43 (7%) in group 2
exhibited that ﬁnding. This difference was found
to be statistically signiﬁcant (P = .01). However,
the mean QRS duration was not found to be sig-
niﬁcantly longer (P = .07) in group 1 (158 ±
28 ms) compared with group 2 (149 ± 19 ms).
Evidence of actual arrhythmias was obtained
from combined ECG, stress tests, and ambula-
tory monitoring. These ﬁndings included multi-
focal PVCs, couplets, triplets, ventricular
tachycardia and ﬁbrillation, atrial reentry tachy-
cardia, atrioventricular (AV) node reentry tachy-
cardia, and atrial ﬂutter and ﬁbrillation. Of the
59 patients with documented arrhythmias, 38
(64%) exhibited a ventricular substrate, 14 (24%)
atrial, ﬁve (9%) both atrial and ventricular, and
the remaining two patients had only evidence of
AV node dysfunction (second or higher degree of
AV block). Among the patients with a ventricular
substrate, 11 patients were in Lown’s grade C,
class 3 (multifocal PVCs), 15 patients were in
grade C, class 4a and 4b (couplets/triplets), and
15 patients had evidence of nonsustained/
sustained ventricular tachycardia or ventricular
ﬁbrillation.
Electrophysiology Data
Intracardiac EPS were performed in 35/59 (59%)
patients with evidence of clinical arrhythmias, pri-
marily to discern the possibility of ablation and/or
need for an ICD placement. Referral for intracar-
diac study was at the discretion of the primary
cardiologist. Comparable clinical arrhythmias
were induced in 27 (77%) of these patients. Induc-
ible atrial arrhythmias occurred in 10 patients:
intraatrial reentrant tachycardia (six), AV nodal
reentry (one), atrial ﬁbrillation (one), His bundle/
junctional (one), and ectopic atrial tachycardia
(one). Sustained ventricular arrhythmias were
induced in 17 patients; 16 of these arrhythmias
were monomorphic, whereas one was polymor-
phic degenerating to ventricular ﬁbrillation.
Among these ventricular arrhythmias, 11 were
entrained from the RVOT and/or VSD patch
margin, two from RV apex, and four from the left
ventricle.
AV node dysfunction was documented in three
patients although clinical AV nodal dysfunction,
as noted above, was found in eight patients. Sinus
node dysfunction was found in two patients. The
above numbers are not mutually exclusive. Five
patients in this group with a positive EP study
had a pacemaker implantation and ﬁve had ICD
placements. The other 12 patients with inducible
ventricular arrhythmias either had a nonsustained
ventricular arrhythmia that was successfully
ablated or were controlled on medications
(class I, III, or beta-blockers). A negative EP
study was documented in eight patients. In all
patients who underwent an EP study, 5/7 (72%)
with evidence of clinical atrial arrhythmia had a
positive EP study for comparable atrial arrhyth-
mias. Similarly, for clinical ventricular arrhyth-
mias, 17/26 (65%) patients had a positive EP
study.
MRI Data
As MRI use among patients with repaired TOF is
a relatively recent clinical tool, in only a subset of
our patients (n = 41) was data obtained. There
were no signiﬁcant differences in the right ven-
tricular end diastolic volumes (RVEDVi) per
patient body surface area between the two groups
(162 mL/m2 in group 1 vs. 154 mL/m2 in group 2,
P = .6). Similarly, there were no differences in the
RV ejection fraction or the pulmonary regurgita-
tion fraction (deﬁned as the retrograde pulmonary
ﬂow/antegrade pulmonary ﬂow × 100%) between
the two groups (Table 1).
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Subgroup Analysis of Patients with
Ventricular Arrhythmias
Patients with ventricular arrhythmias (group 3)
were compared with patients without arrhythmias.
No difference was found between these two
groups with regards to the RVSP, RVOT gradient,
QRS duration, presence of moderate to severe RV
enlargement, and presence of free pulmonary
insufﬁciency (PI) and RVEDV on MRI (Table 2).
Discussion
Patients with TOF remain at high risk for mor-
bidity and late mortality, even years after repair.7,11
Based on our current study, approximately 70% of
patients present with symptoms such as fatigue,
palpitations, syncope, and overt congestive heart
failure. Studies in the past have shown a 10–80%
incidence of signiﬁcant arrhythmias in patients
after TOF repair.2,7,12 Our study shows a 54% inci-
dence of any arrhythmias. As ventricular dysfunc-
tion and elevated pressures can contribute to atrial
arrhythmias leading to patient complaints, all
clinical arrhythmias were included in this study.
Also, atrial arrhythmias are a source of signiﬁcant
morbidity in this patient population, accounting
for symptoms such as dizziness and presyncope
and the need for frequent cardioversion. Previ-
ously, age at intracardiac repair has been shown to
be an important determining factor responsible
for arrhythmias in these patients.7,12 Staged repair
with an initial aortopulmonary shunt has been
shown to increase the risk of late arrhythmias.
Chowdhury et al. in their report suggested that
long-term hypoxemia resulting from the aorto-
pulmonary shunt contributes to myocardial dys-
function and the propensity for ventricular
arrhythmias.13 Repair with a transannular patch
has also been implicated to increase the risk for
late arrhythmias and sudden death.7,14 Our study,
however, does not conﬁrm these ﬁndings.
Although there was a signiﬁcant difference in the
age of intracardiac repair, there were no differ-
ences in history of prior aortopulmonary shunt
surgery or the type of intracardiac repair between
the arrhythmia and arrhythmia-free groups in our
study, similar to the results reported by Harrison
et al.15 Similarly, no signiﬁcant difference in the
incidence of arrhythmias was seen among patients
who had a transannular patch during repair.
Institutional operative technical differences may
account for some of these differences among
reported studies. Hemodynamic abnormalities in
the form of an elevated RVSP (>60 mm Hg) and
an increased RVOT pressure gradient are believed
to be important contributors toward arrhythmias
Table 2. Comparative Demographic, Clinical, Echocardiographic, Electrocardiographic, and MRI Data among Patients
with/without Ventricular Arrhythmias
Group 3 (V. Arrhythmias) Group 2 (No Arrhythmias) P value
Demographic data
Number of patients 43 50
Mean age (years) 32.8 (10.6) 25 (8.3) .002
Mean follow-up (years) 26.1 (8.9) 20.6 (7.1) .003
Surgical characteristics
Mean age at repair (months) 49.9 (50.7) 29.5 (38.2) .04
Palliation 30 (59%) 24 (51%) 1.0
Type of repair
Transannular patch 26 (65%) 33 (67%) .8
No transannular patch 03 (8%) 05 (10%) 1.0
RV to PA conduit 11 (28%) 11 (22%) 1.0
Prior aorto-pulmonary shunt 23 (62%) 27 (57%) .8
Echocardiography
Patients with RVSP ≥60 3 (10%) 5 (14%) 1.0
Mean RVSP (mm Hg) 41.2 (14.2) 37.1 (13.2) .2
Patients with RVOT gradient ≥20 8 (32%) 9 (24%) .5
Mean RVOT gradient (mm Hg) 17.4 (13.1) 17.6 (16.8) .9
Patients with moderate to severe PI 30 (77%) 35 (74%) 1.0
Mean LVEF (%) 64.1 (7.5) 64.3 (7.7) .9
Mean FS (%) 35.9 (4.7) 34.9 (5.8) .5
Electrocardiogram
Patients with QRS duration ≥180 ms 7 (19%) 3 (7%) .1
Mean QRS duration (ms) 152 (25) 149 (19) .5
MRI
RVEDVi (mL/m2) 163 154 .5
FS, fractional shortening; LVEF, left ventricular ejection fraction; PI, pulmonary insufficiency; RA, right atrium; RVOT, right ventricular outflow tract; RVSP, right
ventricular systolic pressure; V, ventricular.
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and sudden death in this population.4,5,16 Our study
did not show a difference in the mean RVSP
between the two groups, and interestingly, the
mean RVSP in both groups was much lower than
the 60 mm Hg level that has been proposed in
older studies, as a risk factor for arrhythmias.
Moreover, clearly, there was no correlation of
arrhythmias with mean RVOT gradient, similar to
the results of the study by Gatzoulis et al.7 Pulmo-
nary insufﬁciency has also been implicated as an
important risk factor.4,5,7 However, there was no
signiﬁcant difference in the number of patients
with moderate to severe pulmonary insufﬁciency
between the two groups in our study, comparable
with other earlier reports.15,17 We also could not
establish a correlation between moderate to severe
RV dilatation and risk of arrhythmias in general,
among our study population, as shown by previous
studies.18 We also studied the QRS duration of our
population. Other studies have proposed the elec-
tromechanical interaction of signiﬁcant pulmo-
nary insufﬁciency and RV dilation contribute to
deleterious EP sequelae.19 Earlier studies had
shown that a QRS duration of >180 msec has a
100% sensitivity for sustained ventricular tachy-
cardia and a 100% negative predictive value if it
was <180 msec.6 A subsequent study by Gatzoulis
et al., however, found that the absolute QRS dura-
tion at any given time may not be of prognostic
signiﬁcance.7 At their latest evaluation, three (7%)
of our patients in group 2 had a QRS duration of
≥180 msec, whereas 27% of the patients in group
1 had a QRS duration of ≥180 msec. These
numbers were statistically signiﬁcant. Also, the
mean QRS duration was higher in the arrhythmia
group (158 msec vs. 149 msec) although not sta-
tistically signiﬁcant unlike previous studies.6–8,18 Of
note, the mean QRS duration of our patients with
arrhythmias is lower than that seen in previous
studies as compared with Gatzoulis et al. (mean
QRS duration for all arrhythmias ranges between
167 and 192 msec).7 Recently, studies have focused
on determining if left ventricular dysfunction is an
important contributor toward arrhythmia genera-
tion and sudden death in this population.10,20 This
report found no differences between the two
groups in mean LV ejection fraction. Recognizing
the fact that the risk factors for atrial and ventricu-
lar arrhythmias are different, we performed suba-
nalysis of patients with ventricular arrhythmias
with the patients with no arrhythmias and found
no difference between the two groups in all the
above-tested parameters. Small sample size pre-
cluded analysis of patients with only atrial arrhyth-
mias and their comparison with the ventricular
arrhythmia group. The importance of EP studies
in predicting risk of arrhythmias and sudden death
in adults with repaired TOF has been reported in
some previous studies.9 However, other reports
have shown that EP studies by themselves may not
be sufﬁcient to predict risk of life-threatening
arrhythmias and sudden death.21 As ventricular
dysfunction and elevated end-diastolic pressures
can contribute to atrial arrhythmias leading to
patient complaints, all clinical arrhythmias were
included in this study. Also, atrial arrhythmias are
a source of signiﬁcant morbidity in this patient
population, accounting for symptoms such as diz-
ziness and presyncope and the need for frequent
cardioversion.22 Hence, we considered it prudent
to include atrial arrythmias in our arrhythmia
group (group 1).
Lastly, we found a low incidence of SCD in our
patient population in deference to studies from
previous eras.1,2 This ﬁnding, in the current era,
supports the previous suggestion that long-term
relative tissue hypoxia resulting from the aorto-
pulmonary shunt contributes to eventual myocar-
dial cellular dysfunction and the propensity for
ventricular arrhythmias that increases the risk
of SCD.13
Conclusion
Results from this study reiterate the fact that
patients with repaired TOF continue to be at risk
from late morbidities including arrhythmias, both
atrial as well as ventricular. However, a high rate of
mortality was not seen in our study cohort. This
study did not reproduce the previously cited cor-
relations performed in the 1980s between type of
repair and risk of arrhythmias and sudden death
in this patient population. However, it should be
noted that the mean age of repair in our study
population was younger than that seen in those
previous studies. The theory that a shorter dura-
tion of hypoxemic damage to the myocardium, as
seen following a shunt procedure prior to deﬁni-
tive repair, appears to have some credibility. Our
study did not ﬁnd any correlation between the
hemodynamic abnormalities and arrhythmia gen-
eration in spite of the presence of a transannular
patch and free PI in a signiﬁcant number of our
patients. In this current study, only a longer QRS
duration was convincingly found to be predictive
of arrhythmias, albeit at a much lower value than
previously cited in various studies. Hence, catego-
rization of these patients for need of pulmonary
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valve replacement or other interventions based on
risk for life-threatening arrhythmias could not be
established. In this regard, the adult with repaired
TOF remains a demanding patient group that
requires continuous follow-up care.
Limitations
We encountered inherent limitations of a retro-
spective study from a single institution. A small
sample size with limited number of adverse events
was our biggest limitation. Our study group com-
prised a referral based biased group of patients.
This would imply that asymptomatic adult
patients, not currently being seen clinically, may
alter the current ﬁndings if added to the patients’
database. Nevertheless, the fact that all patients
seen had their surgical repairs performed from a
single surgical team removes some degree of tech-
nical bias to the ﬁndings.
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